• Biotechnology and Bioprocess Engineering:BBE
• /
• 제9권1호
• /
• pp.47-51
• /
• 2004

Ceramide III was prepared by the cultivation of Saccharomyces cerevisiae. Ceramide III was partitioned from the cell extracts by solvent extraction and analyzed by Normal Phase High Performance Liquid Chromatography (NP-HPLC) using Evaporative Light Scattering Detector (ELSD). We experimentally determined the mobile phase composition to separate ceramide III with NP-HPLC. Three binary mobile phases of n-hexane/ethanol, n-hexane/lsoprophyl Alcohol(IPA) and n-hexane/n-butanol and one ternary mobile phase of n-hexane/IPA/methanol were demonstrated. For the binary mobile phase of n-hexane/ethanol, the first mobile phase composition, 95/5(v/v), was step-increased to 72/23(v/v) at 3 min. In the binary mobile phase, the retention time of ceramide III was 7.87min, while it was 4.11 min respectively in the ternary system, where the mobile phase composition of n-hexane/IPA/methanol, 85/7/8(v/v/v), was step-increased to 75/10/15(v/v/v) at 3 min. However, in the ternary mobile phase, the more peak area of ceramide III was observed.

• 대한화장품학회지
• /
• 제30권3호
• /
• pp.419-426
• /
• 2004

나노 세라마이드의 캡슐화(Nano-ceramide capsulation)는 세라마이드 III와 토코페릴리놀레이트를 나노 크기의 모노 베지클에 캡슐화시켜 피부각질층에 작용하도록 만든 기술이다. 그 제조에는 고압 마이크로플루다이저를 사용하였으며 조성은 다음과 같다. 모노 베지클의 막 강화제로서 $0.5{\~}5.0\;wt\%의$ 수소첨가레시친과 $0.1{\~}2.0\;wt\%의$ 리소레시친을 사용하였으며, 용제로서 $5.0{\~}10.0\;wt\%의$ propylene glycol과 $5.0{\~}10.0\;wt\%의$ ethanol을 사용하였다. 피부 보습기능과 아토피 치료를 위하여 활성성분인 세라마이드 III와 토코페릴리놀레이트를 사용하였으며 유화제는 함유하지 않았다. 나노 세라마이드 캡슐기술의 최적조건은 다음과 같다. 마이크로플루다이저의 통과압력은 1,000 bar, 통과횟수는 3회, 통과 온도는 $60{\~}70^{\circ}C가$ 적당하였다. 또한, nano capsule의 pH는 $5.8\pm0.5이었다.$ 평균입자크기는 $63.1{\pm}7.34 nm로$ 물과 같은 투명한 성상을 보였으며, 제타포텐셜값은 $-55.1{\pm}0.84mV이었다.$ 임상실험 결과로서, 피부보습효과(in-vivo, n=8, p-value<0.05)는 비교시료보다 $21.15{\%}$ 개선되었으며, 치료 전보다는 $36.31{\%}$ 개선되었다. 더구나, 아토피 피부 효과는 아토피 피부 환자 10명에게서 양성반응을 보였다.

• 대한화장품학회:학술대회논문집
• /
• 대한화장품학회 2003년도 IFSCC Conference Proceeding Book II
• /
• pp.268-279
• /
• 2003

The nano capsulation of the ceramide was a technique that capsulated ceramide III and tocopheryl linoleate at the mono-vesicle, so as to act the horny layer in skin. It was used 0.5-5.0 wt% of hydrogenated lecithin and 0.01~2.00 wt% of lysolecithin as the membrane-strengthen agents of the mono-vesicle, 5.0~10 wt% of propylene glycol and 5.0~10.0 wt% of ethyl alcohol made by high-pressure Microfluidizer. To enhance the moisturizing efficacy and treat an atopy skin, used ceramide III and tocopheryl linoleate as the active ingredients, and it was made the nano-capsule that synthetic emulsifiers were free. The optimal condition of capsulation of nano ceramide was as follows. The conditions were 3 times at 1,000bar and 60-7$0^{\circ}C$. The particle size showed 63.1$\pm$7.34 nm such as the transparence water as the results for measuring by the laser light scattering. A zeta potential value was -55.1$\pm$0.84 ㎷. The result of the clinical test, the moisturizing effect (in-vivo, n=8, p-value<0.05) was improved 21.15% compared to control, as well as it was improved 36.31 % before the treatment. Moreover, the effectiveness of atopy skin indicated positive reaction that patients were 10 volunteers.

• 공업화학
• /
• 제21권6호
• /
• pp.603-609
• /
• 2010

수첨 인지질의 하나인 distearoylphosphatidylcholin (DSPC)을 주로 하면서 피부보습에 도움을 주는 용매인 glycerin (GLY)에 의해 팽윤되어 형성된 라멜라 액정상 구조에 피부장벽을 구성하는 지질 중 하나로서 ceramide 3 (CER3)이 함께 배향될 때 나타나는 함량 의존적 거동을 DSC, XRDs, PM 및 Cryo-SEM에 의해 고찰하였다. CER3은 매우 결정성이 높지만, DSPC와의 구조적인 유사성을 가지고 있어 DSPC 20.0 wt% 함량대비 7.0 wt%까지는 탈리 없이 배향되지만, 그 이상을 배향시킬 경우 CER3이 액정 내에서 탈리되어 자체로 GLY에 팽윤되어 또 다른 액정상을 형성하는 것을 XRD의 특성피크 발현과 DSC의 공융점 거동을 통해 확인할 수 있었다. 또한 CER3이 액정 내에 배향되면서 DSPC만으로 이루어진 액정에서 보이는 SPP패턴뿐만 아니라, 피부 각질층에서 주로 나타나는 LPP패턴도 SAXD분석을 통해 확인되어, CER3을 적용시 인간피부와 보다 흡사한 액정구조를 형성함을 확인하였다. Cryo-SEM을 이용하여 DSPC만으로 이루어진 액정과 여기에 CER3이 도입된 액정을 비교한 결과, CER3은 액정의 구조를 보다 두텁고, 견고하게 함을 알 수 있었다.

• Bulletin of the Korean Chemical Society
• /
• 제28권6호
• /
• pp.1021-1030
• /
• 2007

The effects of the creamide III (CER3) and cholesterol (CHOL) on the structure of a non-hydrous distearoyl phosphatidylcholine (DSPC)-based lamellar liquid crystal (LC) hydrated by only propylene glycol (PG) without water were investigated by differential scanning calorimetry (DSC), X-ray diffractions (XRDs), and polarized microscope (PM). As soon as CER3 was incorporated into the lamellar phase, the characteristic LPP was appeared as well as the characteristic SPP, and the formation of separated CER3 crystalline phase was observed depending upon the increase of CER3 content by XRDs. Also, by DSC, it was shown that the increase of CER3 made the monotectic thermal transition be changed to the eutectic thermal transition which indicates the formation of separated CER3 crystalline phases and the main transition temperatures (Tc1) to be gradually decreased and the enthalpy change (ΔH) to be linearly increased. Incorporating CHOL, the formation of LPP and SPP showed almost similar behaviors to CER3, but incorporating small amounts of CHOL showed the characteristic peaks of CHOL which meant the existence of crystalline CHOL phase due to the immiscibility of CHOL with DSPC swollen by PG differently from CER3, and increasing CHOL made the intensity of the 1st order diffraction for LPP weakened as well as the intensities of the characteristic diffractions for DSPC. Also, in the results of DSC, it showed more complex thermal behaviors having several Tc than CER3 due to its bulky chemical structure. In the present study, the inducement of CER3 and CHOL as other lipids present in human stratum corneum (SC) into a non-hydrous lamellar phase is discussed in terms of the influence on their structural and thermal transition.

• Archives of Pharmacal Research
• /
• 제24권2호
• /
• pp.136-143
• /
• 2001

Fumonisins are specific inhibitors of ceramide synthase in sphingolipid metabolism. An alteration in sphingolipid metabolism as a result of fumonisin exposure is related to cell death (Yoo et al., 1992). The objective of this study was to investigate whether elevated free sphinganine levels are related to the sensitivity of cultured cells to fumonisin exposure. Fumonisin $B_1$ elevated the intracellular free sphinganine concentraions in both LLC-$PK_1$ and Chinese hamster ovary (CHO) cells. However, CHO cells are resistant to fumonisin cytotoxicity at 50${u}m$, while LLC-$PK_1$ cells are sensitive at concentrations greater than 357M. The intracellular concentration of free sphinganine in LLC-$PK_1$ cells treated at 50${u}m$ fumonisin $B_1$ for 72 h was approximately 1450 pmol/mg protein relative to the 37 pmol observed in the control culture. Under the same conditions, the population of apoptotic cells in the 50${u}m$ fumonisin $B_1$-treated culture was approximately 37% of the total compared to 12% in the control. The caspase III-like activity after 72 h in the 50${\mu}$M fumonisin $B_1$-exposed culture Increased to approximately 50 $pmol/mg$ protein/hr compared to 6 $pmol/mg$ protein/hr in the control. L-cycloserine, a serine palmitoyltransferase inhibitory reduced the fumonisin $B_1$-stimulated caspase III-like activity down to the control level. Under the same culture conditions, the intracellular concentration of free sphinganine after-cycloserine plus fumonisin $B_1$ treatment was 140 pmol/mg protein compared to 1450 $pmol/mg$ protein in fumonisin $B_1$ alone. The intracellular concentration of free sphinganine in CHO cells treated with 50${u}m$ fumonisin $B_1$ for 72 h was al)proximately 460 pmol/mg protein, indicating that the mass amount of elevated free sphinganine in the CHO cells was about 32% of that in LLC-$PK_1$ cells. Adding exogenous sphinganine to the CHO cells along with 50${u}m$ fumonisin $B_1$ treatment for 72 h caused both necrosis and apoptosis. In conclusion, the elevated endogenous sphinganine acts as a contributing factor to the fumonisin-induced cell death.